PMVP
Pmv Pharmaceuticals Inc
Precision oncology company developing p53-targeted therapies
CUSIP: 69353Y103HealthcareUS1 holder
Total Value
$93.78M
Total Shares
2.64M
Net Share Change
+2.64M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$93.78M2.64M sharesNEW